BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1531 related articles for article (PubMed ID: 33501984)

  • 1. Measuring the global disease burden of polycystic ovary syndrome in 194 countries: Global Burden of Disease Study 2017.
    Liu J; Wu Q; Hao Y; Jiao M; Wang X; Jiang S; Han L
    Hum Reprod; 2021 Mar; 36(4):1108-1119. PubMed ID: 33501984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global, regional, and national burden of infertility attributable to PCOS, 1990-2019.
    Liu X; Zhang J; Wang S
    Hum Reprod; 2024 Jan; 39(1):108-118. PubMed ID: 38011904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence, incidence and years lived with disability due to polycystic ovary syndrome in 204 countries and territories, 1990-2019.
    Safiri S; Noori M; Nejadghaderi SA; Karamzad N; Carson-Chahhoud K; Sullman MJM; Collins GS; Kolahi AA; Avery J
    Hum Reprod; 2022 Jul; 37(8):1919-1931. PubMed ID: 35586937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global, regional, and national burden of premenstrual syndrome, 1990-2019: an analysis based on the Global Burden of Disease Study 2019.
    Liu X; Li R; Wang S; Zhang J
    Hum Reprod; 2024 Jun; 39(6):1303-1315. PubMed ID: 38689567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Oesophageal Cancer Collaborators
    Lancet Gastroenterol Hepatol; 2020 Jun; 5(6):582-597. PubMed ID: 32246941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The global burden of disease attributable to high body mass index in 195 countries and territories, 1990-2017: An analysis of the Global Burden of Disease Study.
    Dai H; Alsalhe TA; Chalghaf N; Riccò M; Bragazzi NL; Wu J
    PLoS Med; 2020 Jul; 17(7):e1003198. PubMed ID: 32722671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 DALYs and HALE Collaborators
    Lancet; 2018 Nov; 392(10159):1859-1922. PubMed ID: 30415748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 DALYs and HALE Collaborators
    Lancet; 2017 Sep; 390(10100):1260-1344. PubMed ID: 28919118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of Burden in Polycystic Ovary Syndrome at Global, Regional, and National Levels from 1990 to 2019.
    Gao Y; Liu H; Qiao L; Liang J; Yao H; Lin X; Gao Y
    Healthcare (Basel); 2023 Feb; 11(4):. PubMed ID: 36833096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The global, regional, and national burden of stomach cancer in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease study 2017.
    GBD 2017 Stomach Cancer Collaborators
    Lancet Gastroenterol Hepatol; 2020 Jan; 5(1):42-54. PubMed ID: 31648970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The epidemiology of pregnancy loss: global burden, variable risk factors, and predictions.
    Tong F; Wang Y; Gao Q; Zhao Y; Zhang X; Li B; Wang X
    Hum Reprod; 2024 Apr; 39(4):834-848. PubMed ID: 38308812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global, regional, and national trends in osteoarthritis disability-adjusted life years (DALYs) from 1990 to 2019: a comprehensive analysis of the global burden of disease study.
    Ding Y; Liu X; Chen C; Yin C; Sun X
    Public Health; 2024 Jan; 226():261-272. PubMed ID: 38134839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015.
    GBD 2015 Tobacco Collaborators
    Lancet; 2017 May; 389(10082):1885-1906. PubMed ID: 28390697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Cirrhosis Collaborators
    Lancet Gastroenterol Hepatol; 2020 Mar; 5(3):245-266. PubMed ID: 31981519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global, regional, and national burden of cervical cancer for 195 countries and territories, 2007-2017: findings from the Global Burden of Disease Study 2017.
    Zhao M; Wu Q; Hao Y; Hu J; Gao Y; Zhou S; Han L
    BMC Womens Health; 2021 Dec; 21(1):419. PubMed ID: 34922503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global, regional, and national burden of brain and other CNS cancer, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Brain and Other CNS Cancer Collaborators
    Lancet Neurol; 2019 Apr; 18(4):376-393. PubMed ID: 30797715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019.
    GBD 2019 Adolescent Young Adult Cancer Collaborators
    Lancet Oncol; 2022 Jan; 23(1):27-52. PubMed ID: 34871551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiological trends of tracheal, bronchus, and lung cancer at the global, regional, and national levels: a population-based study.
    Deng Y; Zhao P; Zhou L; Xiang D; Hu J; Liu Y; Ruan J; Ye X; Zheng Y; Yao J; Zhai Z; Wang S; Yang S; Wu Y; Li N; Xu P; Zhang D; Kang H; Lyu J; Dai Z
    J Hematol Oncol; 2020 Jul; 13(1):98. PubMed ID: 32690044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the Global Burden of Disease Study 2019.
    GBD 2019 Benign Prostatic Hyperplasia Collaborators
    Lancet Healthy Longev; 2022 Nov; 3(11):e754-e776. PubMed ID: 36273485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global burden and risk factors of musculoskeletal disorders among adolescents and young adults in 204 countries and territories, 1990-2019.
    Guan SY; Zheng JX; Sam NB; Xu S; Shuai Z; Pan F
    Autoimmun Rev; 2023 Aug; 22(8):103361. PubMed ID: 37230312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 77.